Telomere length changes in patients with aplastic anaemia.

Area of Science:

• Hematology
• Genetics
• Cell Biology

Background:

• Aplastic anaemia (AA) is a rare but serious bone marrow failure disorder.
• Telomere length (TL) is a biomarker for cellular aging and genomic instability.
• Understanding telomere dynamics in AA may offer insights into disease pathogenesis.

Purpose of the Study:

• To investigate telomere length (TL) in patients with aplastic anaemia (AA).
• To explore the relationship between TL and clinical factors, including treatment response.
• To assess the influence of telomere dynamics on AA pathophysiology.

Main Methods:

• Peripheral blood mononuclear cells from 42 AA patients and 39 controls were analyzed for TL using Southern blot.
• Patients were categorized based on treatment: supportive care only or immunosuppressive therapy (IST).
• TL was compared between patient groups and controls, and correlated with clinical parameters.

Main Results:

• AA patients exhibited significantly shorter mean TL (1.41 kb shorter) than age-matched controls (P < 0.001).
• Non-responders to IST had significantly shorter TL than controls (P < 0.001), while responders showed no difference.
• Telomere shortening correlated positively with neutropenia severity (P = 0.05) and elevated mean corpuscular volume (P = 0.005).

Conclusions:

• Haematopoietic stem cells in AA patients experience rapid telomere attrition early in the disease.
• Telomere shortening in AA may serve as an indicator of impaired haematopoiesis and disease severity.
• TL dynamics warrant further investigation in the context of AA treatment strategies.